Return-Path: Delivered-To: info@sterlingcal.com Received: from reseller401.webserversystems.com by reseller401.webserversystems.com with LMTP id bcXTLR339GeowQYAchKAPA (envelope-from ) for ; Tue, 08 Apr 2025 05:14:53 -0500 Return-path: Envelope-to: info@sterlingcal.com Delivery-date: Tue, 08 Apr 2025 05:14:53 -0500 Received: from mail-yb1-f175.google.com ([209.85.219.175]:45508) by reseller401.webserversystems.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256 (Exim 4.98.1) (envelope-from ) id 1u25ym-00000001r7S-3SFf for info@sterlingcal.com; Tue, 08 Apr 2025 05:14:53 -0500 Received: by mail-yb1-f175.google.com with SMTP id 3f1490d57ef6-e6a8aa771e8so4547103276.3 for ; Tue, 08 Apr 2025 03:14:47 -0700 (PDT) ARC-Seal: i=2; a=rsa-sha256; t=1744107282; cv=pass; d=google.com; s=arc-20240605; b=iCxReN3y9mbuEt6k5a0I/K+eA2kEe2M9FeJLYB1/+NGiTOFu6IhF/O+2MkUaOM1Hh0 mf8Ew7m7nHu2R1JZ+oeS8jcdVqJfvXCF3uLkHCojn0x9wdcLUfR1DLcZ4jG/5cXALCy3 SJO6DHEcGz1VJTL9ISHwm0k4mi0Gzx+dMpBj3ink1fuPl8bsxSGYnZ7i0vAa84Uk/6CD OFKyTXV1kIxedtPd7TJBQmR08JkU+VczK0GEn6Zk+WjRejeNEe2+AmGRrJbnH4xTflAy /+UF5Z8JKVDId8sggUIuTOA1TE2SN6UhpvyaCF3SNBRYTUQFP7y6VsHlU/oBRQAIcWDr YB9g== ARC-Message-Signature: i=2; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=list-unsubscribe:list-unsubscribe-post:precedence:mime-version :subject:message-id:to:reply-to:from:date:dkim-signature :delivered-to; bh=vHBIYDIx05ua/ux7ug0gkJBZF942T0i0ypMTsVpNZUc=; fh=hn8yVJTaZ9csOctGZJu1B0OVMZYfLwtaHDCvk3Up8zc=; b=cGs/J9h+dUaUmduXj6+fx27U6ZDZ8TgW2jMchQwhKJ3CT9LMX27gjM9uInUGO/yzwZ Y5bQ7YKVnG24+KmTIWuC66itXvvQ5Zo1DDQJF/EfTlh2lvOxVsyUfm0NwylqSiDovqaE E45FHeO8Pad6wZDMomVpS0mTKkWxt2v0fr1q1dDG/pS1aaY+KlPdvLFwObF6n+cWwHW1 zmofTeZZH8lK9rVljFU2Ur1vzwCe3Xf04u/pQbdK1pPvDkjS1qCRuO2m+Q9TdzKTzMcg 9+DwfpIjam5JcncXDDRfI/bSS17I83H7W6lzkIiM6cSiMYGzwYQD4R7pG2wPyBWIou+u tqBA==; darn=sterlingcal.com ARC-Authentication-Results: i=2; mx.google.com; dkim=pass header.i=@theskimm.com header.s=sailthru header.b=Ceb1nK0r; spf=pass (google.com: domain of delivery_20250408061413.39331425.505635@bounce.theskimm.com designates 192.64.237.81 as permitted sender) smtp.mailfrom=delivery_20250408061413.39331425.505635@bounce.theskimm.com; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=theskimm.com X-Google-DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=1e100.net; s=20230601; t=1744107282; x=1744712082; h=list-unsubscribe:list-unsubscribe-post:precedence:mime-version :subject:message-id:to:reply-to:from:date:dkim-signature :delivered-to:x-forwarded-for:x-forwarded-to:x-gm-message-state:from :to:cc:subject:date:message-id:reply-to; bh=vHBIYDIx05ua/ux7ug0gkJBZF942T0i0ypMTsVpNZUc=; b=R57YyaGG4w8Sp8qSsfJNG3Osm1fj/lslcA3sOuf7mu+5plosrWzxR8nKRxISMT28R3 bw0qWSecJDowAZOGYMdhE3nBmR7lH5s0QW1t4c00Yaj7zwpSRTh+FIioWDgcK6BX2adQ Je5DDKBv5ajeDLcQQqrBtUGsvQxc8qbGk/9KmO58doeuk9pkQ1hWJrIDeKBiKhNJWof2 LkIkR2uw4G5XsoueDp8uwtCUI5yM5tIW70+zdb0u+zgGnEIHhpLXTOIuOr1velUp06Fo 8x6NXCe0zHYfZl5bisgxDp0y4VFNsw9wep8G3QkYyFUbvHd9ECsyRf9kYBxD0Bpgt9E2 QCmQ== X-Forwarded-Encrypted: i=2; AJvYcCUP5bUkJJW3+1TGt3xp9FS11sOauxTZPUpJ4Rl0EqM+1tpoQ5TTnXTeyYw6LHu8Y/r3EtDi@sterlingcal.com X-Gm-Message-State: AOJu0YyUjshakei9T4SK3L8ay+yM0tKocUTnKwhQfwPfFrr+norI8HwM qCaLkmd6ksD0vfQBs1mv0rwKj+XIT79kKhUuPoFu4ReTMuGf1knSa77MqvMXALJisZ85saZeY8h kUSlfasq/cHoX4QblWS4zPJVm4vlQt1hnaifRaKOwPDgWD8tavrCNonHF0g== X-Received: by 2002:a05:690c:b13:b0:6ef:6f24:d093 with SMTP id 00721157ae682-703e14f5f9emr269895407b3.6.1744107281675; Tue, 08 Apr 2025 03:14:41 -0700 (PDT) X-Forwarded-To: info@sterlingcal.com X-Forwarded-For: sterlingwhg@gmail.com info@sterlingcal.com Delivered-To: sterlingwhg@gmail.com Received: by 2002:a05:7108:4c0f:b0:410:2b1:8e20 with SMTP id il15csp6608558gdb; Tue, 8 Apr 2025 03:14:39 -0700 (PDT) X-Google-Smtp-Source: AGHT+IH3HxrwZFltOY0aDImVQ3uZ7wFgj+1YmW42ICZ209JkhCABhdT3TDYugHAasxwqnBBbMJMV X-Received: by 2002:ad4:5c8d:0:b0:6e8:92c6:9396 with SMTP id 6a1803df08f44-6f00df8d551mr287818756d6.27.1744107279574; Tue, 08 Apr 2025 03:14:39 -0700 (PDT) ARC-Seal: i=1; a=rsa-sha256; t=1744107279; cv=none; d=google.com; s=arc-20240605; b=kIcEPfMccCYlt+IBPe6COFKAyh2gQrKLp8uCGkltdYO8LbkDbR8vJbp7arKf5Sod59 etnkiCjwXJBlXaYdMjIDx0bxdORA5MpXguIuPUFqXcREXL8l3QFnX5//7rEBlbE5tYln jF0uUA3Gt6ArpylRWmrkfqofdWvtYkRhKU92e3Bm/m1isSq+JIBbG9qkTZDwOAG8UWt8 q8rVoiLp75KocH9tErvoapaYcxqNGnyvykH5HziuVeCrRBP5R4x1JANYalva/dqckAgP mzPNUCloB7HBwKdJMrmWKtFY74fSJJ4EImcUEg/FlOVC4TcZwuyuHolbZMN6xeuh0lWv 0Vug== ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20240605; h=list-unsubscribe:list-unsubscribe-post:precedence:mime-version :subject:message-id:to:reply-to:from:date:dkim-signature; bh=vHBIYDIx05ua/ux7ug0gkJBZF942T0i0ypMTsVpNZUc=; fh=8UYCoDTSPITTsMXAEjF6f0Ce+R5+Pgj4Ub+HJhE1UC4=; b=Ve/e711gqRjzk/ACn32OoqtkGFxUyxXh3lig7O49jw/EjnbEQJ6yWGpJzqqoBR4hUN nMS5obk2W1w1dUuogHqv1tpOC/sIeekjYa/PCiA+H6cT5R5wxccjrRzsfHbEDKeFAxD4 82VSPk5NqjL10W5Qspvzf83bsX+PNYIo6lKdQiNq9WLCUhbknJLJ5kflAmGfxXvvRBaw KYw5ZHSMFolRlHSJ96Eyl9dYqhJYXJQnOE1Kv176qjUI6AbTfUthpaCIGjWmwnyFAEkP yTh3s3ngH9W8Ijhxd08pJqVy54IscdSRvrWftHzl4d+DKd/MEHhuMJ4OsSlE9B9l/pBB 6t3w==; dara=google.com ARC-Authentication-Results: i=1; mx.google.com; dkim=pass header.i=@theskimm.com header.s=sailthru header.b=Ceb1nK0r; spf=pass (google.com: domain of delivery_20250408061413.39331425.505635@bounce.theskimm.com designates 192.64.237.81 as permitted sender) smtp.mailfrom=delivery_20250408061413.39331425.505635@bounce.theskimm.com; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=theskimm.com Received: from theskimm-d.sailthru.com (theskimm-d.sailthru.com. [192.64.237.81]) by mx.google.com with ESMTPS id af79cd13be357-7c76ea8fadasi1079661285a.350.2025.04.08.03.14.39 for (version=TLS1_3 cipher=TLS_AES_256_GCM_SHA384 bits=256/256); Tue, 08 Apr 2025 03:14:39 -0700 (PDT) Received-SPF: pass (google.com: domain of delivery_20250408061413.39331425.505635@bounce.theskimm.com designates 192.64.237.81 as permitted sender) client-ip=192.64.237.81; Authentication-Results: mx.google.com; dkim=pass header.i=@theskimm.com header.s=sailthru header.b=Ceb1nK0r; spf=pass (google.com: domain of delivery_20250408061413.39331425.505635@bounce.theskimm.com designates 192.64.237.81 as permitted sender) smtp.mailfrom=delivery_20250408061413.39331425.505635@bounce.theskimm.com; dmarc=pass (p=QUARANTINE sp=QUARANTINE dis=NONE) header.from=theskimm.com DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; s=sailthru; d=theskimm.com; h=Date:From:Reply-To:To:Message-ID:Subject:MIME-Version:Content-Type: List-Unsubscribe-Post:List-Unsubscribe; i=dailyskimm@morning7.theskimm.com; bh=vHBIYDIx05ua/ux7ug0gkJBZF942T0i0ypMTsVpNZUc=; b=Ceb1nK0rGGLhZC0FPLtCAIm86RhpCZ+JDZvDw4t5BkMBcu3K0OYQV9yU4J4cY7rjeTQsBuTtPYto FE6vlyQWMKp822BtAvZuewC0p6GuGndlNIe7Q69cz3BNJrXWAEsDq/SHMDZTyYRpHvQNfTxMRck1 LQjfLDkbBFqugV9i1MY= Received: from aws1-mta-relay2.sailthru.cloud (10.55.73.49) by theskimm-d.sailthru.com id hujrgu3791sp for ; Tue, 8 Apr 2025 05:14:22 -0500 (envelope-from ) Date: Tue, 8 Apr 2025 06:14:13 -0400 (EDT) From: The Daily Skimm Reply-To: dailyskimm@theskimm.com To: sterlingwhg@gmail.com Message-ID: <20250408061413.39331425.505635@sailthru.com> Subject: Upgrade your walk MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_Part_397819_57681272.1744107253868" Precedence: bulk x-job: 7595-39331425-20250408 X-Feedback-ID: 7595:39331425:campaign:sailthru X-TM-ID: 20250408061413.39331425.505635 X-Info: Message sent by sailthru.com customer theSkimm, Inc X-Info: We do not permit unsolicited commercial email X-Info: Please report abuse by forwarding complete headers to X-Info: abuse@sailthru.com X-Mailer: sailthru.com X-JMailer: aws-campaign-mailer-25.sailthru.cloud List-Unsubscribe-Post: List-Unsubscribe=One-Click X-Unsubscribe-Web: https://link.theskimm.com/oc/5bae87c32ddf9c633b058037nf0bl.au5f/2f3a55d4 List-Unsubscribe: , X-rpcampaign: stlgd39331425 X-Spam-Status: No, score=-3.1 X-Spam-Score: -30 X-Spam-Bar: --- X-Spam-Flag: NO ------=_Part_397819_57681272.1744107253868 Content-Type: text/html; charset=utf-8 Content-Transfer-Encoding: quoted-printable
Daily Skimm
3D"" 3D""=E2=80=94 C= heck out what we Skimm=E2=80=99d for you today

Let us help with the tough stuff

3D"Let

Skimm+ is a new membership that helps you live one step ahead= . Just one way we=E2=80=99re doing that: our thoughtfully crafted scripts f= or life=E2=80=99s tricky conversations. Join the waitlist to be notified when a Founding Member spot is op= en for you. 

Join the waitlist
=
<= div hidden=3D"" style=3D"font-family: 'GT America', sans-serif;">

Just Trust Us

These tasty, sugar-free drink mixes are packed with electrolytes that help regulate mood, digestion, energy = levels, and skin health =E2=80=94 and Skimm=E2=80=99rs can get a free sample pack.*

The new BabyBj= =C3=B6rn Baby Crib seamlessly transitions from bassinet to crib, so= you can invest now and forget about it until they're ready for a big-kid b= ed. Bonus points for easy setup and sleek design.

Confused about what, exactly, a "spring shoe" is?= Understandable. You can't go wrong with slim sne= akers, water-repellent clogs, and= classic ballet flats. Try the ballet sneaker, if you dare.

We can't stop talking about Gap's glow-up. In our = carts right now: these extremely chic linen pants and the ma= tching button-down. Thank you, creative director Zac Posen.

Psst=E2=80=A6love our= recs? Follow @skimmshopping on Instagram = for more products, gifts, and services that are actually worth the hype (an= d the price tag).

=

Tell Us=

3D"Store

Do you think the US is al= ready in a recession?

=
Yes
No
<= /table>

Extra Credit

Stream

The end is here: The Han= dmaid=E2=80=99s Tale=E2=80=99s sixth and final= season premieres on Hulu today (the first three episodes are avail= able to stream now). The last installment of the Emmy-winning dystopian dra= ma picks up where season five left off =E2=80=94 with June (Elisabeth Moss)= coming face-to-face with Serena Joy (Yvonne Strahovski) on a train of Gile= ad refugees headed to Vancouver. From there, things get...complicated, as J= une continues her fight to take down Gilead, Luke (O-T Fagbenle) and Moira = (Samira Wiley) join the resistance, and Serena joins forces with Commander = Lawrence (Bradley Whitford) in a "propulsive fina= l season" that "recaptures the urgency and watchability of its earl= y episodes." Praise be.

For more recs...

Check out the Daily Skimm Week= end newsletter, in your inbox every Saturday and Sunday. We'll help you spe= nd your leisure time well.

<= /tr>

Skimm'd by: Rashaan Ayesh, Molly Longman, Maria del Ca= rmen Corpus, and Marina Carver. Fact-checked by Sara Tardiff.

Photos by Ale= x Pena/Anadolu, Alex Wong, and Yuki Iwamura/Bloomberg via Getty Images, Bra= nd Partners, and Disney/Steve Wilkie

D= esign by theSkimm

*PS: This is a sponsored post= .

IM= PORTANT SAFETY INFORMATION

<= b>What is the most important information I should know about ZURZUVAE= ?            &n= bsp;

ZURZUVAE may c= ause serious side effects, including:

  • = Decreased ability to drive or do other dangerous activities. ZURZUVAE may decrease your awareness and alertness, which can affect = your ability to drive safely or safely do other dangerous activities

  • Do not drive, operate machinery, or= do other dangerous activities until at least 12 hours after takin= g each dose during your 14-day treatment course of ZURZUVAE

    <= /li>

  • You may not be able to tell on your own if you can d= rive safely or tell how much ZURZUVAE is affecting you

Decreased awareness and alertness [central nervou= s system (CNS) depressant effects]. ZURZUVAE may cause sleepines= s, drowsiness, slow thinking, dizziness, confusion, and trouble walking

=

  • Because of these symptoms, you may be at a higher ri= sk for falls during treatment with ZURZUVAE

  • Taki= ng alcohol, other medicines that cause CNS depressant effects, or opioids w= hile taking ZURZUVAE can make these symptoms worse and may also cause troub= le breathing 

  • Tell your healthcare provider= if you develop any of these symptoms, or if they get worse during treatmen= t with ZURZUVAE. Your healthcare provider may decrease your dose or stop ZU= RZUVAE treatment if you develop these symptoms

ZURZUVAE is a federal controlled substance (C-IV) because it cont= ains zuranolone, which can be abused or lead to dependence. Keep ZURZUVAE i= n a safe place to protect it from theft. Do not sell or give away ZURZUVAE,= because it may harm others and is against the law.

Before taking ZURZUVAE, tell your healthcare provider= about all of your medical conditions, including if you:

    =

  • drink alcohol

  • have abused or = been dependent on prescription medicines, street drugs, or alcohol

    • =

  • have liver or kidney problems

  • are pregnant or plan to become pregnant. ZURZUVAE may harm your unborn bab= y

  • are breastfeeding or plan to breastfeed. ZURZU= VAE passes into breast milk, and it is not known if it can harm your baby. = Talk to your healthcare provider about the risks and benefits of breastfeed= ing and about the best way to feed your baby during treatment with ZURZUVAE=

Females who are able to become pregna= nt: 

  • Tell your healthcare provide= r right away if you become pregnant during treatment with ZURZUVAE.

  • You should use effective birth control (contraception) = during treatment with ZURZUVAE and for 1 week after the final dose

    • =

  • There is a pregnancy registry for females who are expose= d to ZURZUVAE during pregnancy. The purpose of the registry is to collect i= nformation about the health of females exposed to ZURZUVAE and their baby. = If you become pregnant during treatment with ZURZUVAE, talk to your healthc= are provider about registering with the National Pregnancy Registry for Ant= idepressants at 1-844-405-6185 or visit online at https://womensmentalhealt= h.org/research/pregnancyregistry/antidepressants/

Tell your healthcare provider about all the medicines you take,= including prescription and over-the-counter medicines, vitamins= , and herbal supplements. ZURZUVAE and some medicines may interact with eac= h other and cause serious side effects. ZURZUVAE may affect the way other m= edicines work, and other medicines may affect the way ZURZUVAE works. =

Especially tell your healthca= re provider if you take antidepressants, opioids, or CNS depressants such a= s benzodiazepines. 

= What should I avoid while taking ZURZUVAE?

  • Do not drive a car, operate machinery, or do= other dangerous activities until at least 12 hours after taking e= ach dose of ZURZUVAE because ZURZUVAE may make you feel sleepy, = confused, or dizzy

  • Do not dr= ink alcohol or take other medicines that make you sleepy or dizzy while tak= ing ZURZUVAE without talking to your healthcare provider

See =E2=80=9CWhat is the most important information I sh= ould know about ZURZUVAE?=E2=80=9D

ZURZUVAE may cause serious side effects, including:<= /b>

See =E2=80=9CWhat is the m= ost important information I should know about ZURZUVAE?=E2=80=9D=

  • Increased risk of suicidal thoughts or = actions. ZURZUVAE and other antidepressant medicines may increas= e the risk of suicidal thoughts and actions in people 24 years of age and y= ounger. ZURZUVAE is not for use in children

    • How can I watch for and try to prevent suicidal t= houghts and actions? 

    • Pay close a= ttention to any changes, especially sudden changes in mood, behavior, thoug= hts, or feelings, or if you develop suicidal thoughts or actions. This is v= ery important when an antidepressant medicine is started or when the dose i= s changed

    • Tell your healthcare provider right aw= ay if you have any new or sudden changes in mood, behavior, thoughts, or fe= elings

    • Keep all follow-up visits with your healt= hcare provider as scheduled. Call your healthcare provider between visits a= s needed, especially if you have concerns about symptoms=E2=80=A8

      • <= /ul>

      Tell your healthcare provider right away if you= have any of the following symptoms, especially if they are new, worse, or = worry you:=E2=80=A8

      • attempts to commit= suicide

      • thoughts about suicide or dying

      • new or worse depression

      • feel= ing very agitated or restless

      • trouble sleeping (= insomnia)

      • new or worse anxiety

      • panic attacks

      • new or worse irritabilit= y

      • acting aggressive, being angry, or violent

        =

      • an extreme increase in activity and talking (mania)=

      • acting on dangerous impulses

      • other unusual changes in behavior or mood=E2=80=A8

      The most common side effects of ZURZUVAE include:

      • Sleepiness or drowsiness, dizziness, comm= on cold, diarrhea, feeling tired, weak, or having no energy, and urinary tr= act infection

      These are not all of the possible= side effects of ZURZUVAE.  Call your doctor for medical advice about = side effects. You can report side effects to FDA at 1-800-FDA-1088 or www.f= da.gov/medwatch.

      What is ZURZU= VAE=C2=AE (= zuranolone) CIV?

      ZURZUVAE is= a prescription medicine used to treat adults with postpartum depression (P= PD). 

      It is not known if ZURZUVAE = is safe and effective in children. 

      Prescribing Information= , including Boxed Warning and Medication Guide.

      Sponsored by= Sage Therapeutics, Inc. and Biogen Inc.

      <= div hidden=3D"" style=3D"font-family: 'GT America', sans-serif;">

------=_Part_397819_57681272.1744107253868--